NCT01519713View on ClinicalTrials.gov

Study of a Single Dose of Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine (SP284) in Japanese Subjects

PHASE3CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

September 30, 2012

Study Completion Date

December 31, 2012

Conditions
MeningitisMeningococcal MeningitisMeningococcal Infections
Interventions
BIOLOGICAL

Meningococcal polysaccharide diphtheria toxoid conjugate

0.5 mL, Intramuscular

Trial Locations (3)

Unknown

Nagoya

Osaka

Shinjuku

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT01519713 - Study of a Single Dose of Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine (SP284) in Japanese Subjects | Biotech Hunter | Biotech Hunter